Cargando…

Long-term outcome after allogeneic stem cell transplantation in multiple myeloma

The role of allogeneic hematopoietic stem cell transplantation (allo-SCT) in multiple myeloma is controversial. We analyzed the results of 205 patients transplanted in one center during 2000–2017. Transplantation was performed on 75 patients without a previous autologous SCT (upfront-allo), on 74 as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luoma, Sini, Silvennoinen, Raija, Rauhala, Auvo, Niittyvuopio, Riitta, Martelin, Eeva, Lindström, Vesa, Heiskanen, Jouni, Volin, Liisa, Ruutu, Tapani, Nihtinen, Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116307/ https://www.ncbi.nlm.nih.gov/pubmed/33866396 http://dx.doi.org/10.1007/s00277-021-04514-y

Ejemplares similares

Coordinated responses of natural anticoagulants to allogeneic stem cell transplantation and acute GVHD – A longitudinal study
por: Przybyla, Beata, et al.
Publicado: (2017)

Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
por: Ritari, J., et al.
Publicado: (2018)

Genetic polymorphism related to monocyte-macrophage function is associated with graft-versus-host disease
por: Hyvärinen, Kati, et al.
Publicado: (2017)

Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT
por: Ritari, Jarmo, et al.
Publicado: (2019)

Deep Immune Profiling of Multiple Myeloma at Diagnosis and under Lenalidomide Maintenance Therapy
por: Luoma, Sini, et al.
Publicado: (2023)

Meta-Analysis of Genome-Wide Association and Gene Expression Studies Implicates Donor T Cell Function and Cytokine Pathways in Acute GvHD
por: Hyvärinen, Kati, et al.
Publicado: (2020)

RVD induction and autologous stem cell transplantation followed by lenalidomide maintenance in newly diagnosed multiple myeloma: a phase 2 study of the Finnish Myeloma Group
por: Luoma, Sini, et al.
Publicado: (2019)

Donor Haplotype B of NK KIR Receptor Reduces the Relapse Risk in HLA-Identical Sibling Hematopoietic Stem Cell Transplantation of AML Patients
por: Impola, Ulla, et al.
Publicado: (2014)

Mobilization Strategies in Myeloma Patients Intended for Autologous Hematopoietic Cell Transplantation
por: Jantunen, Esa, et al.
Publicado: (2023)

A Phase 3, Randomized, Placebo-controlled Trial of Filgrastim in Patients with Haematological Malignancies Undergoing Matched-related Allogeneic Bone Marrow Transplantation
por: Ernst, Peter, et al.
Publicado: (2008)

Allogeneic peripheral blood stem cell transplantation with anti-thymocyte globulin versus allogeneic bone marrow transplantation without anti-thymocyte globulin
por: Baron, Frédéric, et al.
Publicado: (2020)

Revealing a gap in the clinical competence of nursing staff in nursing homes: a cross-sectional study with the Ms. Olsen test
por: Vikström-Dahl, Irén, et al.
Publicado: (2023)

Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipients
por: Lahtinen, Atte K., et al.
Publicado: (2022)

Allogeneic Stem Cell Transplantation in Multiple Myeloma
por: Greil, Christine, et al.
Publicado: (2021)

Heterogeneity of executive functions among preschool children with psychiatric symptoms
por: Teivaanmäki, Sini, et al.
Publicado: (2019)

Separating the effects of air and soil temperature on silver birch. Part I. Does soil temperature or resource competition determine the timing of root growth?
por: Kilpeläinen, Jouni, et al.
Publicado: (2022)

Role of Allogeneic Transplantation in Multiple Myeloma in the Era of New Drugs
por: Bruno, Benedetto, et al.
Publicado: (2010)

Current Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma
por: Claveau, Jean-Sébastien, et al.
Publicado: (2022)

Prognostic significance of esterase gene expression in multiple myeloma
por: Kumari, Romika, et al.
Publicado: (2021)

Factors influencing extramedullary relapse after allogeneic transplantation for multiple myeloma
por: Vincent, L, et al.
Publicado: (2015)

Allogeneic Transplantation in Multiple Myeloma—Does It Still Have a Place?
por: Gahrton, Gösta, et al.
Publicado: (2020)

Long-term outcomes of allogeneic stem cell transplant in multiple myeloma
por: Schmidt, Walker M., et al.
Publicado: (2023)

Changes in older people’s quality of life in the COVID-19 era: a population-based study in Finland
por: Siltanen, Sini, et al.
Publicado: (2022)

A David and Goliath set-up: a qualitative study of the challenges of ensuring the introduction of cost-effective new cancer medicines in Finland
por: Ollila, Eeva, et al.
Publicado: (2022)

Long-term outcome after allogeneic hematopoietic cell transplantation for myelofibrosis
por: Robin, Marie, et al.
Publicado: (2019)

Association of IL-10 and IL-10Rβ gene polymorphisms with graft-versus-host disease after haematopoietic stem cell transplantation from an HLA-identical sibling donor
por: Sivula, Jyrki, et al.
Publicado: (2009)

A germline exome analysis reveals harmful POT1 variants in multiple myeloma patients and families
por: Hakkarainen, Marja, et al.
Publicado: (2022)

Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma
por: Campbell, P, et al.
Publicado: (2014)

Allogeneic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma Treatment: Is It Still Relevant?
por: Park, Hyunkyung, et al.
Publicado: (2020)

Allogeneic Hematopoietic Transplantation for Multiple Myeloma in the New Drugs Era: A Platform to Cure
por: Mussetti, Alberto, et al.
Publicado: (2020)

The Role of Allogeneic Stem Cell Transplantation in Multiple Myeloma: A Systematic Review of the Literature
por: Khorochkov, Arseni, et al.
Publicado: (2021)

Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT
por: Pavlů, Jiří, et al.
Publicado: (2019)

Next generation proteomics with drug sensitivity screening identifies sub-clones informing therapeutic and drug development strategies for multiple myeloma patients
por: Tierney, Ciara, et al.
Publicado: (2021)

Establishment of a Murine Graft-versus-Myeloma Model Using Allogeneic Stem Cell Transplantation
por: Binsfeld, Marilène, et al.
Publicado: (2014)

Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma
por: Maffini, Enrico, et al.
Publicado: (2019)

Allogeneic stem cell transplant for multiple myeloma & myelofibrosis with split-dose busulfan, fludarabine & cyclophosphamide
por: Trunk, Andrew D., et al.
Publicado: (2023)

Hidden genomic MHC disparity between HLA-matched sibling pairs in hematopoietic stem cell transplantation
por: Koskela, Satu, et al.
Publicado: (2018)

Recurrent Metastasized Parathyroid Carcinoma—Long‐Term Remission After Combined Treatments With Surgery, Radiotherapy, Cinacalcet, Zoledronic Acid, and Temozolomide
por: Storvall, Sara, et al.
Publicado: (2018)

SECOND TRANSPLANTS FOR MULTIPLE MYELOMA RELAPSING AFTER A PRIOR AUTOTRANSPLANT – REDUCED INTENSITY ALLOGENEIC VERSUS AUTOLOGOUS TRANSPLANTATION
por: Freytes, Cesar O., et al.
Publicado: (2013)

Dental Fear and Dental Health and Attendance among Finnish Male Prisoners
por: Vainionpää, Raija, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_03qld9fvf55e7o6u840mhm4bqi